BioSpace News Archive

Deals

Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics

Inotrem S.A. announced a €39 million Series B financing led by Morningside Ventures, joined by Invus with participation from existing investors Andera Partners, Sofinnova Partners and BiomedInvest.

September 12, 2019
·
4 min read
Business

Vertex Announces New Access Agreement with Scottish Government for ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor)

Eligible patients in Scotland will immediately have access to ORKAMBI and SYMKEVI in combination with ivacaftor

September 12, 2019
·
4 min read
Biotech Beach

Innovative Industrial Properties Acquires California Property Portfolio and Enters into Long-Term Leases with Vertical

Acquisition Expands Footprint to 2.2 Million Square Feet in Twelve States

September 12, 2019
·
5 min read
Business

ArisGlobal Will Showcase New Automation Solutions and Strategies to Industry Leaders at 2019 Life Sciences Technology Summit

ArisGlobal announced details of its annual Life Sciences Technology Summit, taking place October 1st - 3rd at the Miami Beach EDITION hotel in Miami Beach, Florida.

September 12, 2019
·
3 min read
Business

Imaging Endpoints Growth Continues with Move to Larger Corporate Headquarters

Imaging Endpoints (IE) has announced the opening of its new corporate headquarters in Scottsdale, Arizona to accommodate the company’s tremendous growth. The company also has an office in Waltham, Massachusetts as well as staff in Europe and Asia.

September 12, 2019
·
2 min read
Business

Bristol-Myers Squibb to Announce Results for Third Quarter 2019 on October 31, 2019

Bristol-Myers Squibb Company will announce results for the third quarter of 2019 on Thursday, October 31, 2019.

September 12, 2019
·
1 min read
Bio NC

Aruna Bio to Present at Exosome Based Therapeutic Development Summit

Presentation will highlight the potential utilization of exosomes as a therapeutic and delivery vehicle for treating neurodegenerative diseases

September 12, 2019
·
1 min read
Drug Development

Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV Congress

Concert Pharmaceuticals, Inc. announced that it will present results from its recently completed Phase 2 trial of CTP-543 in patients with moderate-to-severe alopecia areata.

September 12, 2019
·
4 min read
Business

ZyVersa Therapeutics’ Perspectives on Inflammasomes Reported in BIOCENTURY Innovations Article

ZyVersa Therapeutics, Inc. is pleased to announce that the August 15th edition of BIOCENTURY Innovations reported ZyVersa’s perspectives on inflammasomes.

September 12, 2019
·
2 min read
BioMidwest

Walgreens to Offer 3 Percent Daily Cash on Apple Card with Apple Pay Purchases

Starting on Friday, September 13, Walgreens customers will receive 3 percent Daily Cash when they use Apple Card with Apple Pay on eligible purchases, including prescriptions, made in Walgreens and Duane Reade stores, and for purchases made on the Walgreens app and on walgreens.com.

September 12, 2019
·
2 min read